Results 111 to 120 of about 2,327,860 (219)

The Outcome of Treatment with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Caspian Journal of Neurological Sciences, 2021
Background: Thrombolytic therapy is the recommended treatment of acute ischemic stroke. It is crucial to evaluate the treatment results with recombinant Tissue Plasminogen Activator (r-TPA) in patients with acute stroke.
Alia Saberi, Amirreza Ghayegran, Mojtaba Abbasalizade, Zeinab Ehtiatkar, Samaneh Ghorbani Shirkouhi, Parisa Shahshahani, Hamidreza Hatamian, Sasan Andalib   +7 more
doaj  

Use of tissue plasminogen activator to treat intracardiac thrombosis in extremely low-birth-weight infants

, 2011
Objective: Intracardiac thrombosis is a life-threatening complication of extreme prematurity. We describe the use of tissue plasminogen activator to treat intracardiac thrombosis in extremely low-birth-weight preterm infants.
Paul Clarke, Jayanti Bose, Bose, Jayanti, Clarke, Paul   +3 more
core   +1 more source

Successful thrombolysis using recombinant tissue plasminogen activator in cases of severe pulmonary embolism with mobile thrombi in the right atrium

, 2014
Hereby, we report two cases of acute pulmonary embolism with concomitant right-sided thrombus, which were successfully treated using recombinant tissue plasminogen activator (rtPA).
Ergül, Elif, Mehmet Bostan, Uğurlu, Yavuz, Şatıroğlu, Ömer, Zakir Karadağ, İsmail Şahin, Yavuz Uğurlu, Durakoğlugil, Murtaza Emre, Doğan, Sıtkı, Elif Ergül, Murtaza Emre Durakoğlugil, Bostan, Mehmet, Karadağ, Zakir, Ömer Şatiroğlu, Şahin, İsmail, Sitki Doğan   +15 more
core   +1 more source

PROBING THE CARBOHYDRATE SIDE CHAINS OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR [PDF]

The glycosylation of recombinant tissue plasminogen activator derived from transfected CHO cells was assessed using glycosyltransferases to probe for terminal Gal and GlcNAc residues and solid-state lectin binding assays.
McDowell, William, Hughes, R. Colin, Animashaun, Theresa   +2 more
core   +1 more source

Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor- and kringle 1-domains

, 1992
Chemicals/CAS: Recombinant Proteins; Tissue Plasminogen Activator, EC 3.4.21 ...
Verheijen, J.H., Emeis, J.J.
core  

Low-Dose Intravenous Recombinant Tissue-Type Plasminogen Activator Therapy for Patients With Stroke Outside European Indications

, 2012
Background and Purpose— The purpose of this study was to determine the safety and efficacy of intravenous recombinant tissue-type plasminogen activator (0.6 mg/kg alteplase) within 3 hours of stroke onset in Japanese patients ...
Masatoshi Koga, Yasuhiro Hasegawa, Tetsuya Miyagi, Jyoji Nakagawara, Eisuke Furui, Masato Osaki, Satoshi Okuda, Yoshiaki Shiokawa, Kazumi Kimura, Hiroshi Yamagami, Kazuomi Kario, Yasushi Okada, Kazuo Minematsu, Kazunori Toyoda, Kaoru Endo   +14 more
core   +1 more source

Intraventricular administration of recombinant tissue plasminogen activator for intraventricular hemorrhage in the newborn

, 2003
Intraventricular hemorrhage remains associated with high mortality and morbidity. Its most serious complication is posthemorrhagic hydrocephalus caused by multiple small blood clots obstructing the arachnoid villi.
Arslanoglu, S, Yalaz, M, Kultursay, N, Akisu, M   +3 more
core   +1 more source

Efficacy of Urinary Kallidinogenase Plus Intravenous Recombinant Tissue Plasminogen Activator for Stroke Patients With Extended Window: A Retrospective Analysis. [PDF]

Neurologist, 2023
Li X, Zhang X, Yang Y, Wang H, Zhang J.
europepmc   +1 more source

Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator

Drug Design, Development and Therapy, 2017
Cheung-Ter Ong,1,2 Yi-Sin Wong,3 Chi-Shun Wu,1 Yu-Hsiang Su1 1Department of Neurology, Chia-Yi Christian Hospital, 2Department of Nursing, Chung Jen Junior College of Nursing, Health Science and Management, 3Department of Family Medicine, Chia-Yi ...
Ong CT, Wong YS, Wu CS, Su YH
doaj  

Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke. [PDF]

J Am Heart Assoc, 2023
Huang Y, Gu S, Han Z, Yang Z, Zhong L, Li L, Wang R, Yan F, Luo Y, Borlongan C, Lu J.   +10 more
europepmc   +1 more source